BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014
Advanced Cell Technology Announces 1:100 Reverse Stock Split 8/28/2014
Allenex AB: Sales +15% Jan-Jun 2014 8/28/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
NeuroSigma, Inc. Files Registration Statement for Proposed Initial Public Offering 8/27/2014
Sinovac Biotech Ltd. (SVA) Announces Results Of 2014 Annual General Meeting Of Shareholders 8/27/2014
Transcat, Inc. (TRNS) Increases Secured Revolving Credit Facility 8/27/2014
BioDelivery Sciences International (BDSI) To Host Investor And Analyst Event And Webcast Friday, September 5 On BUNAVAIL™ Launch And Pipeline 8/27/2014
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
Wound Management Technologies, Inc. Announces Its 2014 Annual Meeting Of Shareholders 8/26/2014
Marinus Pharmaceuticals (MRNS) To Ring The Opening Bell Of The NASDAQ Stock Market 8/25/2014
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Landauer (LDR) Declares Regular Cash Dividend 8/25/2014
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Ordinary Shares And American Depositary Shares Of CFR Pharmaceuticals 8/25/2014
Asterias Biotherapeutics Announces Investor Briefing Conference Call And Webcast 8/25/2014
BioGenerator Funds Woman-led EDIS Solutions 8/25/2014
Letter To The Ampio Pharmaceuticals, Inc. (AMPE) Shareholders In Regard To The STEP Study And Ampio's Plans For The Ampion™ BLA 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
Pershing Square Submits Requisite Requests From Allergan Inc. (AGN) Shareholders To Call Special Meeting 8/25/2014
Easton Pharmaceuticals (OP: EAPH) Announces Financing Update; Provides Additional Due Diligence Documents To Canadian Based Brokerage Firm Towards Financing 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Lemelson Capital Comments On Large Institutional Selling In Shares Of Ligand Pharmaceuticals Inc. (LGND) Amidst Company's Insolvency And Mounting Going Concern Risk 8/25/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
NeoGenomics, Inc. (NGNM.OB) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 8/22/2014
Cellectar Biosciences  (NVLT) Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option 8/21/2014
Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution 8/21/2014
Henry Schein, Inc. (HSIC) To Present At Two Investor Conferences In September 8/21/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Marina Biotech, Inc. (MRNA) Regains Compliance With Exchange Act Reporting Obligations 8/21/2014
Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc. 8/21/2014
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 8/21/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/20/2014
Lorus Therapeutics Inc. (LRP) Announces Results Of Annual And Special Meeting Of Shareholders 8/20/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Ocular Therapeutix, Inc. (OCUL) Announces Exercise Of Over-Allotment Option 8/20/2014
Adamis Pharmaceuticals (ADMP) Announces Private Placement 8/20/2014
Celladon Corporation Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/19/2014
Immune Pharmaceuticals, Inc. Announces Approval For Listing On The NASDAQ Capital Market 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) Announces Upcoming 2014 Investor Conference Presentations 8/19/2014
Mallinckrodt Now A Component Of The S&P 500 Index 8/19/2014
Invitation To Extraordinary General Meeting Of Shareholders Of Recipharm AB 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/19/2014
Northwest Biotherapeutics (NWBO) Completes The Closing Of Its $17.5 Million Convertible Note Offering 8/19/2014
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups 8/19/2014
H&Q Life Sciences Investors Declares Stock Distribution 8/18/2014
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014
TNI BioTech Provides 2nd Notice of Annual Meeting September 4, 2014 8/18/2014
Dyadic International, Inc. Files Form 10 Registration Statement 8/18/2014
Insmed Incorporated (INSM) Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares 8/18/2014
Cellectar Biosciences  (NVLT) Announces Pricing Of $12,500,000 Public Offering And Listing On The Nasdaq Capital Market 8/15/2014
NeoGenomics, Inc. (NGNM.OB) Announces Public Offering Of Common Stock 8/15/2014
TNI BioTech Announces An Extension To The Record Date Of Its Wholly Owned Subsidiary, Cytocom Inc., And Dividend Now Set For September 30, 2014 8/15/2014
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/14/2014
Resverlogix Corporation (RVX.TO) Shareholders Approve Additional $30 Million From Citibank Loan 8/14/2014
Immune Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results And Provides Update On Bertilimumab Commencement Of Phase 2 Clinical Trials 8/14/2014
VistaGen Therapeutics, Inc. Announces Reverse Stock Split 8/14/2014
Northwest Biotherapeutics (NWBO) Announces Pricing Of $17.5 Million Offering Of Convertible Notes 8/14/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Novozymes, Inc. (NZYMb.CO) Increases 2014 Profit Outlook 8/14/2014
Celladon Corporation Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 8/13/2014
NanoViricides, Inc. (NNVC.PK) To Ring Opening Bell At New York Stock Exchange 8/13/2014
Insmed Incorporated (INSM) Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Ligand Pharmaceuticals Inc. (LGND) Prices Offering Of $225 Million Of Convertible Senior Notes 8/13/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
Israel's VBL Therapeutics (VBLX) Terminates NASDAQ IPO Due To Shareholder Mishap 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Prices $300 Million Convertible Senior Notes Offering 8/12/2014
Apricus Biosciences (APRI) Enters Into Common Stock Purchase Agreement With Aspire Capital 8/12/2014
Ligand Pharmaceuticals Inc. (LGND) Announces Proposed Offering Of $225 Million Of Convertible Senior Notes And Announces $200 Million Share Repurchase Program 8/12/2014
Insmed Incorporated (INSM) Announces Proposed Public Offering Of Common Stock 8/12/2014
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results 8/12/2014
Cannabis Science Inc. Increases Equity Position To 50.1% In Michigan Green Technologies LLC, Positioning Company As Leader In Evolving Michigan Medical Cannabis And Hemp Industries 8/12/2014
Big Investors Ask Drugmakers And Biotechs To Support Biosimilars 8/12/2014
Orthocell Successfully Lists On Australian Securities Exchange 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Intention To Offer $250 Million Of Convertible Notes 8/11/2014
Cellular Biomedicine Group (CBMG) To Ring The NASDAQ Stock Market Closing Bell 8/11/2014
TONIX Pharmaceuticals, Inc. Announces Transfer To The NASDAQ Global Market 8/11/2014
PDL BioPharma, Inc. (PDLI) Announces Delay In Filing Quarterly Report On Form 10-Q 8/11/2014
Mast Therapeutics (MSTX) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/11/2014
Bio-Techne Declares Dividend 8/11/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 8/8/2014
Galapagos NV (GLPG.BR) Cash Position Of €232 M Provides Solid Basis For R&D Pipeline Investment 8/8/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Press Release Issued Under The Early Warning System/Sale Of Shares Of Nymox Pharmaceutical (NYMX) 8/7/2014
Celladon Corporation Announces Commencement Of Public Offering Of Common Stock 8/7/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
QLT Inc. (QLTI) Announces Adoption Of Advance Notice Policy 8/7/2014
CVS Caremark Corporation (CVS) Announces Cash Tender Offers For Its 6.250% Senior Notes Due 2027, 6.125% Senior Notes Due 2039, 5.750% Senior Notes Due 2041 And 5.750% Senior Notes Due 2017 8/7/2014
Aoxing Pharmaceutical Company Inc. (AXN) Receives Notice Of Extension From NYSE MKT LLC 8/7/2014
AmerisourceBergen Corporation (ABC) Declares Quarterly Dividend 8/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Proposed Offering Of $500 Million Of Exchangeable Senior Notes 8/7/2014
Zoetis (ZTS) Will Hold Its Inaugural Investor Day On November 18 8/5/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 8/4/2014
Telik, Inc. (TELK) Announces Plans For Special Meeting Of Stockholders And Transition To MabVax Therapeutics, Inc. 8/4/2014
Applied Genetic Technologies Corporation Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014
InVivo Therapeutics Corporation (NVIV) Announces Posting Of Management Presentation Recording From Annual Shareholders Meeting 8/1/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 8/1/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014
China Cord Blood Corporation Files Its Annual Report On Form 20-F 7/31/2014
Zealand Pharma  (ZEAL.CO) Reports Increased Lyxumia® Royalty Revenue For H1 2014 And Informs Of Status Update As Provided By Sanofi 7/31/2014
Senomyx, Inc. (SNMX) Announces Corporate Update And Second Quarter 2014 Financial Results 7/31/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 7/31/2014
Incyte Corporation (INCY) Reports 2014 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 7/31/2014
Ocular Therapeutix, Inc. (OCUL) To Ring The NASDAQ Stock Market Closing Bell 7/31/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2014
All Proposals Approved At Teva Pharmaceutical Industries Limited (TEVA)'s Annual Meeting Of Shareholders 7/31/2014
Merck & Co., Inc. (MRK): No Tax Inversions, We Just Want Bolt-On Deals 7/30/2014
ContraFect Corporation (CFRXU) To Ring The NASDAQ Stock Market Opening Bell 7/30/2014
Covance Inc. (CVD) Reports Second Quarter Net Revenue Growth Of 8.0% To $639 Million, Pro Forma EPS Growth Of 21.5% To $0.95 And Adjusted Net Orders Of $773 Million 7/30/2014
Innophos Holdings, Inc. Declares Dividend Of $0.48 Per Share; Increases Rate By 20% 7/30/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 7/30/2014
QIAGEN N.V. (QGEN) Reports Second Quarter And First Half 2014 Results And Announces Launch Of New $100 Million Share Repurchase Program 7/30/2014
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Offering Of Common Stock 7/30/2014
Tauriga Sciences Inc. (TAUG) Approved To Continue Trading On OTCQB Marketplace 7/30/2014
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) (Publ) 7/30/2014
Horizon Pharma To Host Conference Call And Webcast To Discuss Second Quarter 2014 Financial Results On August 7, 2014 7/30/2014
Gevo, Inc. Announces Proposed Public Offering Of Common Stock And Warrants 7/30/2014
La Jolla Pharmaceutical Company (LJPC) Closes Offering Of Common Stock 7/29/2014
SanguiBioTech GmbH Yields Revenues Of Around USD42,000 In Q4 2014 According To Preliminary Figures 7/29/2014
Axxess Pharma, Inc. Announces Audited Financials And S-1 Registration Statement Now Filed With SEC For Up-Listing To Over The Counter Bulletin Board (OTC: BB) Stock Exchange 7/29/2014
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs 7/29/2014
TNI BioTech, Files Definitive Proxy Materials; Mails Letter Urging Shareholders To Vote The Proxy Card 7/28/2014
Asterias Biotherapeutics Announces Live Investor Webcast 7/25/2014
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 7/25/2014
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014
Derma Sciences, Inc. (DSCI) CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting of Shareholders 7/25/2014
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs 7/24/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
Spherix (SPEX) Schedules Shareholder Update Call 7/24/2014
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted Eps Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted Eps Guidance To A New Range Of $4.32 To $4.40 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing 7/24/2014
Charles River Laboratories (Massachusetts) To Webcast Investor Meeting 7/24/2014
Merck & Co., Inc. (MRK) Announces Fourth-Quarter 2014 Dividend 7/24/2014
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014
Sirona Biochem Announces Shares For Services Agreement 7/23/2014
Merge Healthcare (MRGE) Sets Second Quarter 2014 Earnings Call 7/23/2014
BioAmber Inc. Announces Exercise In Full Of Underwriters' Option In Connection With Previously Priced Follow-On Offering 7/23/2014
La Jolla Pharmaceutical Company (LJPC) Announces Proposed Underwritten Offering Of Common Stock 7/23/2014
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS 7/22/2014
Johnson & Johnson (JNJ) Announces $5 Billion Share Repurchase Program 7/21/2014
SAGE Therapeutics Announces Full Exercise Of Over-Allotment Option 7/21/2014
Shareholders Support Management Proposals At SYGNIS’ AGM With Overwhelming Majority 7/21/2014
Sirona Biochem - CEO Letter To Shareholders 7/21/2014
IntelGenx Corp. To Host Management Call 7/21/2014
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut 7/18/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
Centene Corporation Completes Transaction With Spanish Health Management Group 7/18/2014
Valeant Pharmaceuticals International (VRX) Files Investor Presentation 7/18/2014
Laboratory Corporation of America Holdings (LabCorp) (LH) Announces 2014 Second Quarter Results And Increases 2014 EPS Guidance 7/18/2014
SAGE Therapeutics Announces Pricing Of Initial Public Offering 7/18/2014
Vernalis PLC (VNLPY.PK): Notice Of Results For The Six Months Ended 30 June 2014 7/18/2014
Axxess Pharma, Inc. Announces Financial Audits And Form S-1 To Be Filed With SEC Within One Week For Fully Reporting Status 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
Auspex Pharmaceuticals Announces Completion Of Follow On Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 7/17/2014
Celator Pharmaceuticals, Inc. Provides Update On CPX-351 And Technology Platform At Analyst Day 7/17/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Esperion Therapeutics, Inc. (ESPR) To Host Inaugural Analyst And Investor Day 7/17/2014
Skystar Bio-Pharmaceutical (CGPN) Announces $5 Million Registered Direct Offering 7/17/2014
West Pharmaceutical Services Announces 10% Increase In Quarterly Dividend 7/17/2014
DIA Webinar With Veeva Systems, Inc. To Provide Insight On Improving Transparency And Collaboration With Regional Affiliates 7/16/2014
BTG plc (BTG.L): Interim Management Statement And Annual General Meeting 7/16/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
Dipexium Pharmaceuticals (DPRX) To Ring The NASDAQ Stock Market Closing Bell 7/16/2014
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014
InSite Vision (ISV) To Webcast Annual Meeting Of Stockholders On July 16, 2014 7/16/2014
Cellular Biomedicine Group (CBMG) Raises $10 Million In Private Placement 7/16/2014
RestorGenex Announces Closing Of Its Private Placement Of Common Stock 7/15/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
StemCells Inc. (STEM) Announces Proposed $20 Million Offering 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
Celsion Corporation (CLN) To Ring The NASDAQ Stock Market Closing Bell 7/15/2014
TNI BioTech Establishes New Record Date For Spin-Off Stock Dividend Of Cytocom, Inc. Shares 7/15/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
Nuvilex (NVLX) Provides Shareholder Update On Milestone Accomplishments 7/14/2014
Dicerna Pharmaceuticals (DRNA) To Ring The NASDAQ Stock Market Closing Bell 7/14/2014
Sinovac Biotech Ltd. (SVA) Schedules 2014 Annual Meeting Of Shareholders 7/14/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Provide Update On Transaction 7/14/2014
Maxygen, Inc. (MAXY) Announces Revised Record Date For Final Liquidating Distribution 7/14/2014
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/14/2014
Genocea Biosciences Commences Public Offering Of Common Stock 7/14/2014
Helix Biopharma (CC:HBP) Announces Completion Of Private Placement 7/14/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014
PuriCore: Trading Update and Strategic Review 7/11/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014